Single-Dose Nirsevimab Provides Season-Long RSV Protection for Preterm Infants
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
Single-dose nirsevimab successfully reduced rates of respiratory syncytial virus-associated lower respiratory infections and hospitalizations in pre-term infants.
Preliminary evidence suggests infants are unlikely to become infected with SARS-CoV-2 via breast milk.
DNPs of Color launched in May 2020 as a nonprofit organization to promote the professional advancement of DNPs who belong to racial minority groups.
The FDA advises clinicians to report any adverse effects related to hand sanitizer use and to help patients prevent children from ingesting hand sanitizer products.
Johns Hopkins University is now accepting applications to its DNP/MPH program, which will launch in the summer of 2021.
Researchers believe traffic fatalities may have increased in Colorado due to the state’s cannabis tourism industry, which is not as robust in Washington State.
Nursing home residents experienced similar rates of hospital transfers with and without video intervention, suggesting that videos are an ineffective advanced care planning education method.
Offspring of women with chronic hypertension were twice as likely to be hospitalized for an endocrine-related issue by the age of 18.
Antibiotic therapy was found to shorten recovery time for pediatric patients with uncomplicated appendicitis, thereby avoiding surgery.
Researchers sought to examine the safety of aspirin as a primary prevention method for atherosclerotic cardiovascular events in high-risk patients.